Home » News and events » New Tysabri data released

New Tysabri data released

News releases

Biogen Idec and Elan Corporation, plc have announced new data on the global utilization, safety and overall patient exposure of TYSABRI® ((natalizumab); humanized by MRCT). “These data suggest that neurologists and patients are increasingly choosing TYSABRI for the treatment of their disease.” Click here to read the full article on PharmaLive.

WordPress development by Andy White using PorterWP